Dr. Reddy's Laboratories (RDY) and Senores Pharmaceuticals said Tuesday they have launched 3 milligram Ivermectin tablets USP that are therapeutically equivalent to the Stromectol tablets made by Merck (MRK) Sharp and Dohme in the US market.
Dr. Reddy's will market the drug, the companies said.